Cogent Biosciences, Inc. COGT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s total equity?
- Cogent Biosciences, Inc. (COGT) reported total equity of $607.69M in Q1 2026.
- How has Cogent Biosciences, Inc.'s total equity changed year-over-year?
- Cogent Biosciences, Inc.'s total equity increased by 177.5% year-over-year, from $219M to $607.69M.
- What is the long-term trend for Cogent Biosciences, Inc.'s total equity?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s total equity has grown at a 22.1% compound annual growth rate (CAGR), from $234.67M to $636.37M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.